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Background and Purpose: The novel muscarinic cholinergic partial agonist U-80816E was tested in the gerbil brief bilateral carotid occlusion ischemia model based on the rationale that the compound's hypothermic properties might afford effective protection of the selectively vulnerable hippocampal CA1 region.
Methods: Male gerbils were subjected to either 10 or 15 minutes of bilateral carotid occlusion, followed by histopathological assessment of the CA1 neuronal survival 7 days later.
Results: In saline-treated animals, 10 minutes of bilateral carotid occlusion resulted in a 30.5% loss of CA1 neurons, whereas a 15-minute insult resulted in a 49.6% loss. Administration of U-80816E (6 mg/kg i.p. 30 minutes before bilateral carotid occlusion and again 2 hours after reperfusion) resulted in a significant protective effect of the CAl neuronal population with either duration of ischemia; neuronal loss was reduced to 12.6% in the milder model (p<0.05 versus saline-treated) and 24.9% in the more severe model (p<0.04 versus saline). However, the 6 mg/kg i.p. dose of U-80816E was found to produce a 1.0°C decrease in brain temperature (measured with a tympanic temperature probe) at 10 minutes of ischemia compared with that of saline-treated gerbils. At 10 minutes of reperfusion, after the 10-minute episode of ischemia, the brain temperature of the U-80816E-treated gerbils was 2.2°C lower than that of saline-treated animals. When the U-80816E-treated gerbils were subjected to either 10 or 15 minutes of ischemia but placed in a heated chamber that prevented the hypothermic effects, no cerebroprotection was observed.
Conclusions: These results show that the anti-ischemic efficacy of U-80816E is mediated through its One week after BCO, the brains were perfusion fixed with a combination of formaldehyde (10%), acetic acid (10%), and methanol (80%) (FAM) after a saline flush, through cardiac perfusion. Immediately after perfusion, the brains were removed and placed in FAM. The brains were then blocked and the appropriate (1.4-3.0 mm posterior to the bregma) 5-,u dorsal hippocampal sections were mounted on slides and stained with cresyl violet. Examination of tissue was by light microscopy at 320 x magnification. Slide labels were covered with tape to enable blinded cell counts. All undamaged pyramidal cells in a 315 -, length of the central part of the CA1 region of dorsal hippocampus were counted. The CA1 regions of the two hemispheres were averaged.
Results Figure 1 displays the time-course of the hypothermic effects of U-80816E in nonischemic, nonanesthetized gerbils. The U-80816E-treated animals displayed a significant drop in rectal temperature which peaked at 30 minutes after dosing (-1.9°C). By 60 minutes, the body temperature had recovered to the predosing level. However, the temperature of the U-80816E-treated gerbils was significantly lower than that of the salinetreated group at 15 hypothermia nearly identical to the first (-1.8°C), demonstrating the consistency of the hypothermic effects of this compound. The baseline temperature before this dose was higher than the initial temperature before the first dose due to the lack of anesthesia at the time of the second dose. Table 1 shows the rectal and brain (tympanic) temperatures of saline-and U-80816E-treated anesthetized gerbils subjected to a 10-minute period of ischemia (BCO) and 10 minutes of postischemic reperfusion. It is apparent, by comparison with the unanesthetized gerbils in Figure 1 , that anesthesia lowers body temperature rapidly. The mean preischemic rectal temperature in the anesthetized salinetreated animals was 34.8°C. Brain temperatures tended to follow the rectal temperatures. In the U-80816E-treated animals, the rectal temperature was slightly lower (34.1°C), which was not significantly different from that in the saline-treated group. In the salinetreated group, ischemia induction for 10 minutes (without control by placement in the warming chamber) resulted in a further lowering of rectal and brain Figure 2 compares, in animals anesthetized and surgically prepared in identical fashion to those represented in Table 1 , the ability of a hypothermic dose of U-80816E to affect postischemic hippocampal CA1 neuronal necrosis in gerbils subjected to 10 minutes of BCO with and without temperature maintenance. In saline-treated animals, the 10-minute BCO resulted in a 30.5% loss of CA1 neurons at 1 week after ischemia. In comparison, the U-80816E-treated, non-temperaturecontrolled gerbils displayed only a 12.6% loss (p<0.05 versus saline). There It should be noted that the degree of neuronal injury in gerbils not treated with U-80816E, associated with 10 minutes of BCO, is slightly less than that observed by others with only 5 minutes of BCO.9,17 The lesser injury than might be predicted in comparison with other experiments with only 5 minutes of ischemia is no doubt due to the fact that our animals were allowed to manifest a greater drop in temperature (approximately 4°C) during anesthesia than in the work of others. However, despite the likelihood that greater baseline hypothermia in the present experiments may explain the less-than-predicted degree of neuronal damage with 10 minutes of ischemia compared with other studies with 5 minutes of ischemia, temperature control at 35.5°C had only a slight (but not statistically significant) negative effect on CA1 neuronal survival in saline-treated gerbils. On the other hand, the prevention of hypothermia completely antagonized the protective efficacy of U-80816E. Figure 3 shows that U-80816E in non-temperaturecontrolled animals also significantly benefited CA1 neuronal survival after a more severe 15-minute BCO. In saline-treated gerbils, the loss of neurons compared with that in the sham-operated group was 49.6%. This was reduced by approximately half (to only 24.9%) by -.
--L by guest on April 13, 2017 http://stroke.ahajournals.org/ Downloaded from hypothermic dosing with U-80816E. In contrast to the 10-minute BCO, temperature control in the salinetreated group of animals significantly worsened neuronal necrosis (-83.9%) compared with the non-temperature-controlled, saline-treated gerbils. Moreover, it also abolished the protective effect of U-80816E.
Thus, it appears that at least within the present study, temperature control (i.e., prevention of ischemia-induced hypothermia) is more significant in terms of exacerbating neuronal damage in the context of the moderate (15-minute) ischemic insult than in the milder (10-minute) period of ischemia.
Discussion
The results show that the peri-ischemic (30 minutes before plus 2 hours after) administration of hypothermic doses of the muscarinic cholinergic partial agonist U-80816E can produce a significant protective effect on hippocampal CA1 neurons in gerbils subjected to either mild (10-minute) or moderate (15-minute) BCO cerebral ischemia. This protective action would appear to be entirely a manifestation of the compound's hypothermic properties because its prevention by external warming completely antagonizes the pharmacological protection. With both ischemic severities, the administration of doses of U-80816E that produce a 1.0°C intraischemic and 2.2°C postischemic (10 minutes of reperfusion) decrease in body temperature essentially halved the degree of postischemic damage to CA1 neurons. Whether the protective effects in this study are due to intraischemic versus postischemic hypothermia is unknown. Welsh and Harris18 have recently reported that postischemic hypothermia of a magnitude of 5C (33°C versus 38°C) is not protective in the gerbil 5-minute BCO model. Moreover, it has also been shown in a rat forebrain ischemia model that immediate postischemic hypothermia, while somewhat effective in reducing ischemic damage, is not as efficacious as when applied during ischemia.7 Thus, it seems likely that the intraischemic hypothermia induced by preischemic dosing with U-80816E is the more essential therapeutic maneuver in the present experiments. However, it should be noted that the hypothermic effects of ischemia alone were more pronounced than those studied by others with a briefer (5-minute) period of ischemia. Therefore, an exact comparison of our results with those of Welsh and Harris18 is not possible.
As noted above, externally induced hypothermia has been repeatedly shown to attenuate postischemic neuronal damage.1-9 The current experiments show that this can also be achieved pharmacologically. Pharmacological hypothermia may be a more reliable approach to the production of a defined degree of temperature control for a specific duration compared with the application of external cooling.
The mechanism(s) of hypothermic cerebroprotection have not been fully elucidated and are probably multiple. Two 
